Richard B. Vanderveer, Ph.D., CEO of the global pharmaceutical marketing and research firm V2 GfK, presents strategies for enhanced physician targeting and segmentation.
The California legislature recently passed SB 1765 (aka, 'fair drug marketing bill'), which requires pharma companies to comply with PhRMA and OIG Guidelines. this article summarizes the provisions of this bill, which is currently awaiting signature by Governor Schwarzenegger.
This article summarizes the results of a recent Pharma Marketing News Survey on this topic.
Vioxx Withdrawal and the "Me-Too Drug Domino Effect" OpEd by John Mack Merck's "voluntary" withdrawal of Vioxx...
Vol. 3, No. 9: October 2004 - PREVIEW The following are summaries of articles planned for the upcoming October 2004 issue of Pharma Marketing News....
Dear Reader, Welcome to the October 2004 archive of Pharma Marketing News. Vol. 3, No. 9: October 2004 - CONTENTS ...
Several drug re-importation bills are currently being considered in Congress.
Women account for more than half of the population in the United States and it makes absolute sense to market to women where, when, and how they choose.
Multicultural communications can be a powerful addition to the armamentarium of the healthcare marketer.
This article compares pharmaceutical prices paid by governments in the United States and Canada.